Allergios is a startup based in the Netherlands, most recent round Seed, 1 tracked investor.
Allergios is a company founded in 2020 headquartered in the Netherlands. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Allergios develops an AI-powered microfluidic platform for functional allergy diagnostics, aiming to replace risky and resource-intensive oral provocation tests with a cell-based blood test that analyzes individual immune responses to allergens.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.